Chronic Lymphocytic Leukemia responds to a new drug found to have few side effects
(dailyRx News) MChronic lymphocytic leukemia is a type of blood cancer that usually grows slowly and can be treated with chemotherapy. But in some cases, patients do not respond to this traditional treatment.
As the search for safe and effective treatments continues, a new study suggests that chronic lymphocytic leukemia responds to treatment with ibrutinib, a new therapeutic agent.
According to this study, the medication was effective in preventing the cancer from progressing, without any major side effects, as is often experienced with chemotherapy.